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ABSTRACT 
Type 2 diabetes, obesity and depression are growing concerns for human health. Physical 
exercise is a known protective factor against these disorders, although the underlying 
mechanisms are incompletely understood. The studies in this thesis aim to increase the 
understanding of mechanisms controlling gene expression and DNA methylation in the 
context of type 2 diabetes, obesity and exercise. 
TWIST1 and TWIST2 proteins play an important role in embryonic muscle development, 
inflammation and tumor metabolism. We demonstrated that Twist1 or Twist2 overexpression 
in mature skeletal muscle favors glycolysis and increases the expression of pro-inflammatory 
cytokines. Gene expression of TWIST1 and TWIST2 is unaltered by obesity, type 2 diabetes 
or exercise training. 
Decreased circulating kynurenine levels are associated with resistance to depression. 
Kynurenine is transformed into kynurenic acid by kynurenine aminotransferases (KATs). 
Exercise training and PGC1α induce expression of KATs in skeletal muscle. We report that a 
single bout of exercise acutely decreased plasma kynurenine, while concomitantly increasing 
kynurenic acid in both type 2 diabetic and healthy subjects. Exercise-induced changes in 
kynurenine metabolism were independent of mRNA expression of the KATs. Kynurenine 
levels correlated with body mass index, suggesting kynurenine metabolism may link obesity 
and depression. 
Exercise and diet affect skeletal muscle insulin sensitivity and DNA methylation. Using 
genome-wide approaches, we unraveled the effect of exercise on the skeletal muscle 
methylome. Training and high-fat diet, but not in vitro contraction, lead to epigenetic changes 
in the promoter of Sprouty RTK Signaling Antagonist 1 (Spry1), a gene involved in muscle 
stem cell quiescence. We found DNA methylation of Spry1 increased binding of nuclear 
proteins to the promoter. 
Insulin is a metabolic and growth promoting hormone. Using genome-wide approaches, 
we unraveled the effect of insulin on the skeletal muscle methylome. We observed that 
insulin treatment of skeletal muscle in vitro increased DNA methylation of the death-
associated protein Kinase 3 (DAPK3). Conversely, DAPK3 DNA methylation was reduced in 
type 2 diabetic subjects compared to controls. A glucose challenge further decreased DAPK3 
methylation suggesting that additional factors in the systemic milieu may affect DAPK3 
DNA methylation. 
Collectively, our results indicate that TWIST proteins affect skeletal muscle metabolism 
and inflammation. We provide a potential mechanism for the anti-depressive effects of 
exercise and shed new light on the complex interplay between metabolic conditions, skeletal 
muscle and DNA methylation. We provide a new insight in the protective effect of exercise 
or the pathophysiology of type 2 diabetes and obesity, opening opportunities for 
improvements in the management and treatment of metabolic diseases. 
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1 INTRODUCTION 
 
The word metabolism comes from “metabolē”, the Grek word for “change”. Humans, like all 
living creature, “change” nutrients into energy for their survival, growth and activity. All 
transforming processes are part of metabolism. The three principal sources of energy in humans 
are glucose, fat and protein.  
Sufficient glucose availability is critical for certain functions and organs, especially the brain. 
Besides being an energy source, glucose is also important for nucleotide and non-essential 
amino acid synthesis. When glucose intake exceeds expenditure, glucose can be stored as 
glycogen in skeletal muscle and liver or transformed and stored as fatty acids in adipose tissue. 
In case of insufficient glucose intake, amino acids can be used by the liver to produce glucose. 
This is termed “hepatic gluconeogenesis”. 
Blood glucose levels are controlled by a feedback system between two peptide hormones 
produced in the pancreas: glucagon and insulin. Glucagon is secreted by the alpha-cells in 
response to low blood glucose concentration, while insulin is secreted by the beta-cells in 
response to elevated blood glucose concentration. Insulin decreases blood glucose levels by 
triggering glucose uptake in insulin-sensitive tissues such as adipose tissue and skeletal muscle, 
while inhibiting hepatic gluconeogenesis. If these tissues become insulin-resistant, blood 
glucose levels rises and represents a first step towards type 2 diabetes. 
 
 DIABETES MELLITUS 1.1
Diabetes mellitus is usually referred simply as Diabetes. The name was given by the Greek 
physician Aretaeus of Cappadocia (1st century CE). In ancient Greek, diabetes means "a passer 
through” while mellitus comes from Latin and means “honey-sweet”. It refers to a characteristic 
symptom of an untreated person with diabetes: the patient drinks a lot and releases abundant 
quantities of urine containing sugar (sweet water passing through the body). Two main types of 
diabetes mellitus are considered: type 1 and type 2. Type 1 refers to a disease caused by the loss 
of the insulin-secreting beta-cells of the pancreas. If exogenous insulin is not provided rapidly, 
type 1 diabetes is fatal. Type 2 diabetes has a more complex origin and is the topic of the 
present thesis. 
1.1.1 Type 2 Diabetes 
Type 2 diabetes is a complex non-communicable disease defined by chronic elevated levels of 
blood glucose (Table 1). Type 2 diabetes is characterized by a state of insulin resistance in 
metabolically important tissues including skeletal muscle, adipose tissue and liver, often in 
conjunction with impaired insulin secretion by the beta-cells of the pancreas. Type 2 diabetes 
progresses from the somewhat reversible impaired fasting glucose (IFG) and impaired glucose 
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tolerance (IGT) states followed by full blown diabetic state (Saltiel and Kahn 2001). There are 
two main diagnostic tests for type 2 diabetes: the measurement of fasting plasma glucose and 
the measurement of venous plasma glucose two hours after ingestion of a 75g oral glucose load, 
the so called Oral Glucose Tolerance Test (OGTT). 
 
Classification Fasting plasma glucose 
 
2–h plasma glucose 
Impaired fasting glucose 6.1 to 6.9mmol/l (110mg/dl to 125mg/dl) AND <7.8mmol/l (140mg/dl) 
Impaired glucose tolerance <7.0mmol/l (126mg/dl) AND ≥7.8 and <11.1mmol/l (140mg/dl and 200mg/dl) 
Diabetes ≥7.0mmol/l (126mg/dl) OR ≥11.1mmol/l (200mg/dl) 
 
Table 1: Diabetes classification (adapted from WHO 2006). 
 
Over time, high blood glucose leads to inflammation and systemic tissue damage, especially of 
the blood vessels (Giugliano, Ceriello et al. 2008). Microvascular damage leads to nephropathy, 
retinopathy and neuropathy, ultimately resulting in kidney failure, loss of vision and ulceration 
of the foot. Macrovascular damages increase the risk of cardiovascular disease such as 
myocardial infarction and stroke. Additionally, type 2 diabetes increases the risk of major 
depression (Anderson, Freedland et al. 2001; Ali, Jyotsna et al. 2013). 
Acutely, type 2 diabetes is not life threatening. Nevertheless, type 2 diabetes markedly increases 
the risk of fatal coronary heart disease (Huxley, Barzi et al. 2006). Diabetes reduces life 
expectancy dramatically, even in developed countries: In 2003 in the USA “if an individual is 
diagnosed [with type 2 diabetes] at age 40 years, men will lose 11.6 life-years and 18.6 quality-
adjusted life-years and women will lose 14.3 life-years and 22.0 quality-adjusted life-years.” 
(Narayan, Boyle et al. 2003). In 2004, an estimated 3.4 million people died from consequences 
of high blood glucose ((WHO) 2016).  
Type 2 diabetes is a pandemic with an estimated 285 million people suffering from this disease 
in 2010 with a projected rise to 438 million by 2030 (Whiting, Guariguata et al. 2011). Of note, 
type 2 diabetes is not only an occidental problem, but a global concern as prevalence of diabetes 
in rural areas quintuples over twenty-five years in low- and middle-income countries from 1.8% 
in 1985–1989, to 8.6% for 2005–2010 (Hwang, Han et al. 2012) making type 2 diabetes a 
global concern and a heavy burden on society. 
The financial impact of diabetes on the healthcare system is significant. In 2010, around 12% 
of the healthcare spending around the world was attributed to diabetes (Zhang, Zhang et al. 
2010). In the USA, a diabetic patient spends 2.5 times more on medical care than a person 
without the disease (Association 2008). Most statistics refer to “diabetes”, and do not 
  3 
differentiate between type 1 and type 2 diabetes. Type 2 diabetes represents 90-95% of the 
cases (Narayan, Boyle et al. 2003; Boehme, Buechele et al. 2015). 
Risk factors for developing type 2 diabetes as listed by the International Diabetes Foundation 
include, but are not limited to: family history of diabetes, overweight, unhealthy diet, physical 
inactivity, increasing age, high blood pressure, ethnicity, history of gestational diabetes and 
poor nutrition during pregnancy (Federation 2016). Although the pathophysiology of type 2 
diabetes is not fully understood, any reduction of these risk factors through engagement in 
prevention programs is effective (Aziz, Absetz et al. 2015). Treatment of type 2 diabetes is 
based on lifestyle intervention focused on physical activity and diet modification, 
pharmacotherapy and the treatment of incidental complications. 
 
 OBESITY 1.2
Energy metabolism is a tightly regulated balance between food intake and energy expenditure. 
The combination of multiple biological feedbacks through hormonal secretion allow for a tight 
control of hunger and satiety in humans. Nevertheless, an imbalance can occur. Caloric intake 
comes from digestion and absorption of food. Caloric expenditure encompasses basal 
metabolism (the energy necessary to maintain body functions), the thermic effect of food, non-
exercise physical activity and exercise (Figure 1). In humans, most of the energy storage is in 
the form of fatty acids in adipose tissue. If intake surpasses expenditure, fat will start 
accumulating. 
 
 
Figure 1: Graphical Representation of Energy Balance. 
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According to WHO “Abnormal or excessive fat accumulation that may impair health” is the 
definition of obesity ((WHO) 2016). Obesity is commonly quantified using body mass index 
(BMI). BMI is calculated by dividing a person's weight in kilograms by the square of his height 
in meters (kg/m2). Limits for overweight and sub-groups of obesity are presented in Table 2. 
BMI is a simple and useful tool to assess weight to length ratio but is not a measure of body 
composition and can be misleading in some cases. Thus, a more accurate measurement of 
“abnormal or excessive fat accumulation that may impair health” requires other tools such as 
waist to hip ratio, skinfold-thickness measurements or dual-energy X-ray absorptiometry which 
directly measures body composition. 
 
Classification BMI (kg/m2) 
 Overweight 
sub-
classification 
BMI (kg/m2) 
Underweight <18.50  
Pre-obese 25.00 - 29.99 
Normal range 18.50 - 25 
 
 Obese ≥30.00 
Overweight ≥25.00  Obese class I 30.00 - 34.99 
  
 Obese class II 35.00 - 39.99 
  
 Obese class III ≥40.00 
     
Table 2: BMI Classification (adapted from WHO 2004). 
 
The world prevalence of obesity, as assessed by BMI, has more than doubled between 1980 and 
2014. Overall, 13% of the population on the planet was obese in 2014 (Finucane, Stevens et al. 
2011; (WHO) 2016). Forecasts worldwide predict a prevalence of obesity between 20 and 38% 
of the population by 2030 (Kelly, Yang et al. 2008), thus research and enforcement of 
preventive measures and treatment of obesity and related comorbidities should be a public 
health priority. 
Overweight and obesity are known risk factors for many medical conditions such as 
cardiovascular diseases (e.g. stroke), cancer (e.g. colon cancer), musculoskeletal disorders (e.g. 
osteoarthritis), type 2 diabetes, and many more (Guh, Zhang et al. 2009). Every year, 2.8 
million people die prematurely as a consequence of being overweight. An estimated 35.8 
million (2.3%) of global Disability-Adjusted Life Year (DALYs, years of healthy life lost) are 
  5 
attributed to overweight or obesity (Organization 2009). Direct and indirect costs of overweight 
and obesity are heavy on healthcare systems and are most likely going to increase further with 
the rise in BMI worldwide (Dee, Kearns et al. 2014). 
The development of obesity has an environmental and a genetic component (O'Rahilly and 
Farooqi 2000). The recent rise of overweight and obesity prevalence world-wide is mainly 
attributed to changes in lifestyle, including physical inactivity and excessive consumption of 
calorie-dense food ((WHO) 2016). Recent findings in twins reared apart estimate the heritability 
of BMI at 77%, outweighing the contribution of the environment (Wardle, Carnell et al. 2008). 
This suggests that although lifestyle changes trigger the increase in prevalence, genetic 
predisposition plays an important role in the development of obesity. A small portion of obesity 
cases are monogenic as in the case of leptin deficiency (Hamann and Matthaei 1996). Genome-
wide association studies have identified several loci associated with BMI (Waalen 2014) such 
as the FTO (Fat mass and obesity-associated protein) gene variant (Loos and Yeo 2014). 
However, FTO, like other variants, is thought to account for only a limited increase in BMI 
(Frayling, Timpson et al. 2007). Epigenetic modifications may also contribute to the risk of 
obesity and type 2 diabetes, including intrauterine conditions of both under- and over-
nourishment (El Hajj, Schneider et al. 2014). Epigenetic changes could provide a link between 
genetic and environmental influences. .Although several gene loci have been identified and 
different mechanisms proposed, further efforts are necessary to further our understanding of the 
development of obesity.  
Although obesity is a complex, it is also a preventable disease. Preventive measures include 
increased physical activity, a healthy nutrition and social measures. A combination of the 
possible interventions in one coordinated effort (multilevel and multicomponent interventions) 
is being developed and appears to be effective (Ewart-Pierce, Mejia Ruiz et al. 2016). When 
obesity is already established, effective treatments are scarce and expensive, not without 
adverse effects for the patients and often insufficient to fully reverse the condition. 
Nevertheless, they often provide significant improvements in metabolic markers and outcomes 
(Douketis, Macie et al. 2005; Pi-Sunyer, Astrup et al. 2015). The management of obesity 
includes improving lifestyle through dietary recommendations and encouragement of physical 
activity together with behavior therapy. An effective and safe pharmacotherapy is not available 
today but extreme cases of obesity can be improved by bariatric surgery. 
 
 PHYSICAL ACTIVITY & DIET 1.3
With modern technology and comfort, lifestyles have changed drastically and physical activity 
has become a choice rather than a necessity. Being active and exercising reduces the risk of 
diabetes, cardiovascular disease and cancer (Fox 1999; Garber, Blissmer et al. 2011; Reiner, 
Niermann et al. 2013). The lack of physical activity is now the fourth greatest risk factor for 
global mortality. “Approximately 3.2 million deaths and 32.1 million DALYs (representing 
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about 2.1% of global DALYs) each year are attributable to insufficient physical activity” reports 
the WHO (Organization 2009). Thus, exercise is recommended for diabetic, obese and 
depressed patients, as well as healthy people throughout lifetime (Wei, Gibbons et al. 2000). 
Currently, WHO advocates for 150 minutes of vigorous physical activity each week ((WHO) 
2016; (WHO) 2016).  
While the level of physical activity is decreasing, energy intake is on the rise (Austin, Ogden et 
al. 2011). Energy-dense food has been blamed for the global obesity epidemic (Drewnowski 
and Darmon 2005). WHO estimates that 1.7 million of deaths and 16 million of DALYS are 
attributable to low fruit and vegetable consumption each year (Organization 2009). 
Consumption of a sufficient amount of fruits and vegetables has been shown to reduce the risk 
for cardiovascular diseases, stomach cancer and colorectal cancer (Bazzano, Serdula et al. 2003; 
Riboli and Norat 2003). 
 
 DEPRESSION 1.4
Depression, as described in the 10th revision of the International Statistical Classification of 
Diseases and Related Health Problems (ICD-10, 2016) is characterized by a lowered mood, 
reduction of energy and loss of pleasurable feelings. 
Diabetes, obesity and lack of physical activity are linked to depression. Diabetes increases the 
risk of major depression (Anderson, Freedland et al. 2001; Ali, Jyotsna et al. 2013) while 
individuals with depression have an increased risk of diabetes (Nouwen, Winkley et al. 2010). 
Obesity and depression are also associated (Mannan, Mamun et al. 2016; Muhlig, Antel et al. 
2016), while physical activity is an effective treatment for depression (Rethorst, Wipfli et al. 
2009). Skeletal muscle, through kynurenine metabolism, has been postulated to play a role in 
exercise-induced depression resilience (Agudelo, Femenia et al. 2014). 
Psychological, psychosocial and pharmacological treatments have been proven effective in the 
management of depression, but less than 10% of the 350 million people affected receive 
treatment due to lack of resources, lack of trained personal or social stigma associated with 
mental disorders ((WHO) 2016). Exercise could be promoted as a simple and inexpensive 
measure to improve depression symptoms and consequences. 
 
 SKELETAL MUSCLE AND ROLE IN METABOLISM 1.5
Skeletal muscle represents over 40% of total body mass in humans. Skeletal muscle allows us to 
move and interact with our environment. At rest, it consumes 30% of the calories necessary to 
keep the body at steady state, representing a large proportion of basal metabolism (Zurlo, 
Larson et al. 1990). Skeletal muscle is metabolically flexible meaning that it can utilize various 
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fuel sources depending on supply availability and demand (Storlien, Oakes et al. 2004). Skeletal 
muscle is a highly plastic tissue; it is responsive to stimuli from the environment, able to grow 
(hypertrophy as in bodybuilders) or shrink (atrophy, as during immobilization or in cachexia). 
Energy consumption and power output of skeletal muscle can increase to a large extent, as seen 
during intense physical activity, where a large amount of watts and heat are produced.  
Skeletal muscle is the principal tissue responsible for insulin-stimulated glucose disposal and 
the tissue where the reduction in glucose utilization by diabetic subjects is the most striking 
(DeFronzo, Jacot et al. 1981). In insulin-sensitive tissues, insulin binding to cell surface 
membrane receptors induces a chain reaction leading to gene transcription, enhanced glucose 
uptake, storage and oxidation. A key component of the increased rate of glucose uptake after 
insulin stimulation in skeletal muscle is the translocation of the glucose transport (GLUT4) 
proteins to the cellular membrane allowing for an increased amount of facilitated glucose 
transport (Lund, Holman et al. 1997). Type 2 diabetic patients have reduced glucose transport 
following insulin stimulation despite similar amount of GLUT4 transporters within the muscle 
fibers (Handberg, Vaag et al. 1990). In this state, commonly referred as “insulin resistance”, 
insulin signaling is blunted. Impairments in lipid metabolism, as well as inflammation, play 
roles in the development of insulin resistance, but the exact mechanisms of insulin resistance 
are not completely understood (Samuel and Shulman 2012). 
Physical activity and muscle contraction improve insulin sensitivity in skeletal muscle and 
activate several signaling pathways that result in changes in gene expression (Egan and Zierath 
2013). A bout of exercise will trigger or repress the transcription of a wide variety of genes. 
Changes in gene expression occur mainly a few hours after the acute bout of exercise, but also 
up to several days afterwards (Neubauer, Sabapathy et al. 2014). The burst in gene expression 
after exercise is usually followed a few hours later by an increase in protein translation. Over 
the course of training, both protein and mRNA changes lead to muscle remodeling with respect 
to metabolic capacity and physical performance (Perry, Lally et al. 2010). 
Skeletal muscle is organized in multinucleated muscle fibers (Figure 2), and further subdivided 
in myofibrils. Each myofibril is subdivided in contractile units called sarcomeres. Each 
sarcomere is delimited by a Z line. Within a sarcomere are actin and myosin filaments. During 
contraction, actin is pulled along myosin toward the center of the sarcomere. Maximal 
shortening of the muscle is achieved when actin and myosin filaments are completely 
overlapped. 
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Figure 2: Graphical representation of a skeletal muscle fiber. Multiple myofibrils are represented. Sarcomere 
in greater detail (inset). (CC BY 3.0 license. Blausen gallery 2014". Wikiversity Journal of Medicine. 
DOI:10.15347/wjm/2014.010. ISSN 20018762). 
 
To activate skeletal muscle, an electrical signal is sent by the central nervous system to the 
neuro-muscular junction. There, acetylcholine neurotransmitter induces the opening of sodium 
ion channels resulting in depolarization of the fiber. This depolarization causes the release of 
calcium by the sarcoplasmic reticulum. Calcium binds to troponin allowing the myosin to pull 
on actin filaments. This last step consumes ATP and is repeated to induce further shortening of 
the muscle (Field and Society 1983).  
The term myosin encompasses a large family of proteins sharing the ability to bind actin, 
hydrolyze ATP and generate force. In skeletal muscle, the most abundant isoforms are the root 
of the fiber type classification. MYH7 is the gene encoding for the myosin heavy chain-β, the 
main isoform in the slow-twitch type 1 fibers. MYH2 is the gene coding for the fast-twitch and 
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fatigue resistant type 2A fibers while fast-twitch and fatigable type 2X myosin mainly express 
MYH1. Other myosin heavy chain genes are expressed in skeletal muscle such as MYH7b, 
MYH15 and MYH16 (Schiaffino and Reggiani 2011). 
 
 SATELLITE CELLS 1.6
In adult skeletal muscle, muscle-specific stem cells are located between the basal lamina and 
sarcolemma of the fibers. These cells are called satellite cells. In adult muscle, satellite cells are 
in a quiescent state (not dividing) (Schultz, Gibson et al. 1978). In response to mitogenic 
stimuli, satellite cells will activate transcription factors and start proliferating. Specific markers 
of satellite cells are transcription factors PAX3 and PAX7 (Relaix, Rocancourt et al. 2005). 
PAX7 levels will decrease, while MyoD and Myogenin will be expressed. Proliferation and 
asymmetric division of the satellite cells provide myonuclei to repair or support growth of 
muscle fibers (Schultz 1996). Receptor tyrosine kinases are key elements of growth signaling. 
The Sprouty RTK signaling antagonist genes (Spry1-4) are negative regulators of receptor 
tyrosine kinases. In satellite cells, SPRY1 controls quiescence. SPRY1 is expressed in intact 
muscles while it is downregulated in injured muscle to allow for proliferation and growth of the 
satellite cells (Shea, Xiang et al. 2010) (Figure 3). 
 
Figure 3: Satellite cells: After injury, quiescent PAX7+/SPRY1+ cells turn off SPRY1 and enter cell cycling. 
After several rounds of division, a subset of cells turns on SPRY1 again and returns to quiescence. Redrawn and 
adapted from Abou-Khalil and Brack 2010. 
 
 REGULATION OF GENE EXPRESSION 1.7
Nuclear DNA is the genetic code containing all the necessary information for one totipotent cell 
to give rise to a whole multicellular organism containing plenty of different cell types, each 
expressing a very specific set of genes (Mitalipov and Wolf 2009). 75% of the code is 
transcribed into RNA (Djebali, Davis et al. 2012), but the 20,500 protein-coding genes (Clamp, 
Fry et al. 2007) only account for ∼2% of the DNA (Dinger, Pang et al. 2008). Gene expression 
is the medium to go from DNA to the actual macromolecular machinery for a functional cell. 
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Genes are transcribed into RNA to then produce proteins or regulate cell function. Gene 
transcription rate is controlled by proteins called transcription factors as they promote or block 
the transcriptional activity of RNA polymerase enzymes (Latchman 1997; Lee and Young 
2000). A defining feature of transcription factors is the DNA binding domain, a motif that has 
affinity to DNA and which recognizes DNA sequences (Mitchell and Tjian 1989). Transcription 
factors can be classified according to their mechanism of action, regulatory function, or 
structural similarities. In addition to transcription factors, proteins such as coactivators, 
corepressors, chromatin remodelers, and methylases are crucial modulators of transcription 
(Naar, Lemon et al. 2001; Narlikar, Fan et al. 2002). Input signals from the extracellular 
environment alter expression of transcription factors and coregulators (Brivanlou and Darnell 
2002) allowing the cell to adapt to different stimuli. In skeletal muscle, exercise induces 
transcription changes in a wide range of genes (Raue, Trappe et al. 2012; Lindholm, Marabita et 
al. 2014) while myogenesis induces a very different group of genes (Bentzinger, Wang et al. 
2012). 
1.7.1 Myogenesis and the TWIST Proteins 
MyoD, MYF5, Myogenin and MRF4 are the four major transcription factors driving gene 
expression in skeletal muscle differentiation (myogenesis) (Hawke and Garry 2001). Termed 
myogenic regulatory factors (MRFs), all are basic helix-loop-helix proteins (bHLH). Basic 
helix-loop-helix transcription act in homo- or hetero-dimers formed with various other bHLH to 
control gene expression. MyoD was discovered in 1987 as the first case where ectopic 
expression could convert cells such as fibroblasts into skeletal muscle cells (Davis, Weintraub et 
al. 1987), opening the field of cellular reprogramming. The MRFs are also subject to regulation. 
Notably, TWIST1 and TWIST2 proteins, also bHLH, block myogenesis through inhibition of 
MyoD transactivation (Hamamori, Wu et al. 1997) and HDAC recruitment (Qiu, Ritchie et al. 
2006). The mechanism of TWIST transcriptional activity, as for other bHLH, varies depending 
on post-transcriptional modifications, partner choice and cellular context, making the 
characterization of their modes of action a complex task (Castanon, Von Stetina et al. 2001; 
Laursen, Mielke et al. 2007; Sharabi, Aldrich et al. 2008). Numerous biological roles have been 
attributed to the TWIST proteins (Franco, Casasnovas et al. 2011). In addition to repressing 
MyoD, TWIST proteins also play a role in metabolism and inflammation, at least in adipose 
tissue, where TWIST1 silencing reduces fatty acid oxidation and modulate pro-inflammatory 
cytokine expression and secretion (Pettersson, Laurencikiene et al. 2010; Pettersson, Mejhert et 
al. 2011). 
1.7.2 PGC1α 
Another protein of importance for skeletal muscle gene expression regulation is the Peroxisome 
proliferator-activated receptor gamma coactivator 1-alpha (PGC1α, gene name PPARGC1). 
PGC1α is not a transcription factor, but function as a “master regulator” by binding to, and 
modulating the activity of a number of different transcription factors. PGC1α stimulates 
  11 
mitochondrial biogenesis and promotes fatty acid oxidation (Wu, Puigserver et al. 1999). 
Clinically, activation of PGC1α has been implicated in protective effects against type 2 
diabetes, obesity, sarcopenia (Wenz, Rossi et al. 2009) and stress-induced depression (Agudelo, 
Femenia et al. 2014). A number of gene expression responses to resistance and endurance 
exercise are mediated by different PGC1α isoforms (Martinez-Redondo, Jannig et al. 2016). 
1.7.3 Kynurenine Aminotransferases 
Kynurenine aminotransferases (KATs) are four enzymes regulated by PGC1α. KATs have been 
suggested to be involved in the protective effect exercise on depression by acting on the 
tryptophan/kynurenine pathway (Agudelo, Femenia et al. 2014). Tryptophan is an essential 
amio-acid and is also the source of neurotransmitters and neuroactive compounds such as 
serotonin and kynurenine. Kynurenine itself can be transformed either into kynurenic acid 
(through the KATs) or into quinolinic acid (through kynurenine 3-monooxygenase, 
kynureninase and 3-hydroxyanthranilate 3,4-dioxygenase) (Figure 4). Mainly studied in the 
brain, kynurenic acid and quinilonic acid are two different neuroactive metabolites with 
opposing effects. Quinilonic acid is an N-methyl-D-aspartic acid receptor agonist and is formed 
in microglial cells of the brain. Conversely, kynurenic acid antagonizes the NMDA-receptor, 
blocks the cholinergic α7 nicotinic receptor and is produced in astrocytes (Perkins and Stone 
1982). Kynurenine, in contrast to kynurenic acid and quinilonic acid is able to cross the blood 
brain barrier. Kynurenine flux from the periphery into to the brain is associated with an 
increased manifestation of psychiatric disorders such as schizophrenia or depression (Campbell, 
Charych et al. 2014). Intriguingly, increased circulating kynurenic acid is associated with 
resistance to depression (Myint, Kim et al. 2007). A possible mechanism is that peripheral 
tissues, especially skeletal muscle, convert kynurenine into kynurenic acid, preventing 
kynurenine from reaching the brain (Agudelo, Femenia et al. 2014). 
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Figure 4: Schematic Representation of the Kynurenine Pathway. 
 
 EPIGENETICS 1.8
1.8.1 Defining Epigenetics 
Epigenetics is the contraction of the Greek prefix “epi-“, meaning “on top”, and genetics. 
“Epigenetics” has emerged following the word “epigenesis”, the process by which cells 
differentiate and form organs. In 1942 the word “epigenetics” became a field of research with 
Conrad Waddington writing “the task is to discover the causal mechanisms at work, [to 
transition from a genotype to phenotype] and to relate them as far as possible to what 
experimental embryology has already revealed of the mechanics of development. We might use 
the name ‘epigenetics’ for such studies.” (Waddington 2012). Controversy about the exact 
meaning of “epigenetics” was started and continues today (Ledford 2008). Inheritance is the 
main point of controversy. In 1996, Riggs and colleagues describe epigenetics as “the study of 
mitotically and/or meiotically heritable changes in gene function that cannot be explained by 
changes in DNA sequence” (Russo, Martienssen et al. 1996) expressing that epigenetics exclude 
changes in the genome, but without clarifying what phenomenon the work epigenetics 
encompasses. In 2007 Adrian Bird proposed a new definition for the word epigenetics: “the 
structural adaptation of chromosomal regions so as to register, signal or perpetuate altered 
activity states”. Adding the following note “It focuses on chromosomes and genes, implicitly 
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excluding potential three-dimensional architectural templating of membrane systems and 
prions, except when these impinge on chromosome function” (Bird 2007). In this thesis, I will 
refer to epigenetics as in this last citation. With that definition, epigenetics encompasses cell 
programming, the fact that despite a similar genetic code, cell types in the body have a very 
diverse gene expression program and exhibit diverse physical and biological properties. 
1.8.2 Epigenetic Regulation 
Two well characterized epigenetic processes are imprinting and X-inactivation. In imprinting, a 
gene is silenced depending on his parent-of-origin. IGF2 imprinting is an example of maternal 
imprinting (silencing of the maternal copy of the gene) (DeChiara, Robertson et al. 1991). X-
inactivation is the inactivation of one of the two X chromosomes in females (Ng, Pullirsch et al. 
2007). Imprinting and X-inactivation, as all other epigenetic processes, result from multiple 
levels of epigenetic regulation, such as histone modifications, nucleosome positioning, non-
coding RNA and DNA methylation. 
The 2 meter long human DNA needs to be organized and compacted to fit into a cell. For this 
reason, DNA is wrapped more or less tightly around nucleosomes composed of octamers of 
proteins called histones. Each histone presents a tail that can be post-translationally modified to 
alter the configuration of the DNA and thus modulate transcription (Huang, Sabari et al. 2014). 
Several environmental challenges modify the histone tails, including exercise (McGee, Fairlie et 
al. 2009). Advances in genomic technologies have revealed that the position on the DNA 
sequence of the nucleosome formed by histones also impacts DNA transcription (Jiang and 
Pugh 2009). 
Recent advances in sequencing technologies have revealed the existence of several classes of 
non-coding RNAs in addition to previously appreciated species such as ribosomes and transfer 
RNAs. Among these new species are micro-RNAs, long non-coding RNAs and  piwi-
interacting RNAs. Novel non-coding RNAs have been identified in a wide range of sizes, and 
many have not been investigated for their function so far. Some novel non-coding RNAs have 
been implicated in the maintenance of the DNA methylation profile (Di Ruscio, Ebralidze et al. 
2013), connecting these two epigenetic mechanisms. 
1.8.3 DNA Methylation 
DNA is methylated by the addition of a methyl group (CH3) to the fifth carbon atom of 
cytosine. Methylation of the cytosine is catalyzed by DNA methyltransferases (DNMTs). 
DNMT1 is responsible for the maintenance of the methyl marks following DNA replication, as 
in proliferating cells. DNMT3A, and DNMT3B establish “de novo” methylation. The addition 
or removal of methyl groups alters the binding of regulatory elements and thus the transcription 
of the genetic code. In adult mammal cells, cytosine methylation happens essentially in the 
context of a cytosine-guanine dinucleotide (CpG) (Lister, Pelizzola et al. 2009). Cytosine’s 
methylation within another dinucleotide (CpA, CpT,CpC) is termed non-CpG or CpH 
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methylation. 98 % of CpG methylation is symmetrical on both DNA strands, while this occurs 
for only 10% of non-CpG methylation. This is probably linked to the fact that CpA 
dinucleotides are paired with CpT dinucleotides and vice versa on the complimentary DNA 
strand (Shirane, Toh et al. 2013). 
DNA is mostly de-methylated and re-methylated at an early embryonic stage and partially 
during cell division and differentiation. Alterations of the DNA methylation profile also occur 
with aging (Issa 2014), in cancer and several other diseases (Robertson 2005). It has recently 
been appreciated that DNA methylation is a dynamic phenomenon (Kangaspeska, Stride et al. 
2008) influenced by environmental factors (Herceg 2016) and  that these changes may be 
transmitted intergenerationally (Barres and Zierath 2016). 
Most recent studies have focused on CpG methylation which is the most abundant DNA 
methylation mark. However, a role for non-CpG methylation is emerging. Non-CpG 
methylation is more frequent in embryonic and induced pluripotent stem cells (iPSCs) than in 
differentiated cells (Ziller, Muller et al. 2011). Non-CpG methylation is unlikely to be 
transmitted during cell division and would thus need to be re-established after the division 
(Patil, Ward et al. 2014). Nevertheless a few studies have provided evidence that non-CpG 
methylation might play a role, especially in rarely dividing cells such as neurons or skeletal 
muscle (Patil, Ward et al. 2014). 
All epigenetic mechanisms are linked and the sum total of the different effects determines the 
final cellular program. How much each epigenetic mechanism contributes and how different 
mechanisms interact together to alter the structure of chromosomal regions and activity states is 
still to be clarified. 
Understanding epigenetics is of clinical relevance. Epigenetic marks, such as methylation of the 
SEPT9 gene, are already used in the field of cancer as biomarkers to stage disease risk and 
progression (Mikeska and Craig 2014; Tahara and Arisawa 2015; Rasmussen, Krarup et al. 
2016). Epigenetic changes linked to genes encoding for transporters and metabolizing enzymes 
can significantly alter pharmacokinetics of a drug and could be predictive factors of drug 
response (Ivanov, Kacevska et al. 2012). Drugs targeting epigenetic proteins (epidrugs) are 
already used in the clinic. The DNMT1 inhibitor 5-aza-2′deoxycytidine (Azacitidine) has been 
approved for the treatment of myelodysplastic syndrome (Muller and Florek 2010). Altogether, 
progresses in epigenetic research should lead to improved prevention, personalization of 
treatment and may even provide new treatments.  
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2 AIMS 
Physical activity and diet affects skeletal muscle function which in turn has effects on other 
organs such as the brain. The overall aim of this thesis is to identify regulators of gene 
expression relevant for insulin sensitivity and glucose metabolism in healthy, obese and type 
2 diabetic skeletal muscle and to determine how exercise and diet may impact gene 
expression and function.  Progress in these areas could reveal new regulatory mechanisms 
involved in the protective effect of exercise or the pathophysiology of type 2 diabetes and 
obesity, providing avenues for potential improvements in the management and treatment of 
metabolic diseases. 
Specifically, the aims are to: 
1. Determine whether the transcription factors TWIST1 and TWIST2 are involved in 
the regulation of glycogen storage and inflammatory genes in skeletal muscle. 
2. Analyze effects of exercise on the kynurenine pathway in people with normal 
glucose tolerance or type 2 diabetes. 
3. Determine whether endurance training in lean and obese rats alters DNA 
methylation changes in skeletal muscle.  
4. Determine whether insulin directly alters skeletal muscle DNA methylation.  
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3 METHODOLOGICAL CONSIDERATIONS 
 
 HUMAN COHORTS 3.1
Five human cohorts are included in the present work. Biopsies of the vastus lateralis skeletal 
muscle were obtained to analyze gene expression and DNA methylation. From these biopsies 
we also retrieved human primary myocytes that were used in paper 4. We used two different 
techniques to collect the biopsies as detailed below. 
3.1.1 Open Biopsy 
In paper 3, for the in vitro studies, we collected skeletal muscle strips using the “open 
biopsy” technique (Koistinen, Galuska et al. 2003; Pfenninger and Fowler 2011). For this the 
patient lies down in a relaxed position, the skin overlying the skeletal muscle sample to be 
taken is washed with antiseptic and local anesthesia is administered. An incision (4 cm) in the 
vastus lateralis is made 15 cm proximal of the patella. A muscle biopsy (around 2 g) is 
excised and placed in oxygenated Krebs-Henseleit buffer. Hemostasis and closing of the 
wound requires electrocautery and stiches of the skeletal muscle fascia and skin. This 
technique allows for the retrieval of a long portion of the same group of fibers that can then 
be cut in smaller strips as described in paper 4. We subsequently treated each muscle strip 
with different compounds and determined response. 
3.1.2 Needle Biopsy 
Skeletal muscle biopsies used in papers 1, 2 and for the in vivo study in paper 3 were 
retrieved using a “needle biopsy” technique. Washing and local anesthesia are prepared as 
described for the “open biopsy”. A small incision (~ 5 mm) is made in the vastus lateralis 
and a Weil-Blakesley conchotome is introduced to retrieve a skeletal muscle biopsy (~ 100 
mg). Several samples can be collected. Wound closing does not require stiches. The needle 
technique is less invasive and technically easier to perform, but the amount of tissue collected 
is smaller. 
3.1.3 Study Participants 
Clinical characteristics of the five human cohorts presented in this thesis are in Tables 3 and 
4. We used three different cohorts where we compared people with normal glucose tolerance 
(NGT) to type 2 diabetic subjects and 2 other cohorts where only healthy sedentary subjects 
were enrolled. 
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Table 3: Anthropometric and Metabolic Characteristics of Type 2 Diabetic and Normal Glucose 
Tolerant Volunteers  
  Paper 1 Paper 2 Paper 4 
  NGT T2D NGT T2D NGT T2D 
n 10 10 12 12 12 12 
Sex (F/M) 5/5 4/6 0/12 0/12 0/12 0/12 
Age (y) 58 ± 2 63 ± 1* 59 ± 2 58 ± 2 60 ± 3 63 ± 1 
Height (cm) 171 ± 3 170 ± 4 179 ± 2 177 ± 2 178 ± 2 180 ± 1 
Weight (kg) 84.8 ± 3.6 90.8 ± 5.8 84.8 ± 3.4 86.4 ± 4.1 80.8 ± 2.3 91.5 ± 2.0 
BMI (kg/m2) 29.1  ± 0.6 31.3  ± 1.2 26.4  ± 1.0 27.6  ± 1.0 25.4  ± 0.5 28.3  ± 0.6* 
Waist to hip ratio         0.92 ± 0.01 0.98 ± 0.01* 
Waist. circumference (cm) 93.2  ± 2 106.0 ± 4*         
Body fat %     27 ± 2 30 ± 2     
SBP (mmHg) 133  ± 5 140  ± 3     133 ± 5 135 ± 3 
DBP (mmHg) 79 ± 3 78 ± 2     81 ± 3 85 ± 2 
FBG (mmol/L) 5.5 ± 0.0 7.9 ± 0.2* 5.0 ± 0.2 7.7 ± 0.5* 5.3 ± 0.1 8.1 ± 0.4* 
2-h PG (mmol/L) 6.6 ± 0.4 14.5 ± 1.4* 5.6 ± 0.5 14.3 ± 1.1* 5.9 ± 0.3 15.8 ± 1.0* 
Insulin (pmol/L) 51.4 ± 12.5 92.5 ± 16.6* 42.4±6.3 68.8±7.6* 51.2 ± 6.4 100.6 ± 13.9* 
HbA1c (%) 4.6 ± 0.1 5.3 ± 0.2* 5.3±0.1 6.6±0.3* 5.5 ± 0.1 6.9 ± 0.2* 
HbA1c,mmol/mol         35 ± 1 49 ± 3* 
HDL (mmol/L) 1.58 ± 0.14 1.24 ± 0.05* 1.39 ± 0.12 1.22 ± 0.08 1.3 ± 0.06 1.3 ± 0.08 
LDL (mmol/L) 3.24 ± 0.18 2.74 ± 0.28 3.24 ± 0.18 2.15 ± 0.19* 3.4 ± 0.14 2.8 ± 0.26* 
TG (mmol/L) 1.45 ± 0.33 1.24 ± 0.11 0.96 ± 0.10 1.26 ± 0.16 0.98 ± 0.16 1.22 ± 0.15 
Total cholesterol, 
(mmol/L)     5.07 ± 0.21 3.94 ± 0.20
* 5.1 ± 0.2 4.6 ± 0.2 
HOMA-IR 1.97 ± 0.10 3.48 ± 0.30* 1.38±0.24 3.30±0.53* 1.59 ± 0.2 5.42 ± 0.9* 
NGT, normal glucose tolerant subjects; T2D, type 2 diabetes subjects; BMI, Body Mass Index; SBP, Systolic 
Blood Pressure; DBP, Diastolic blood pressure; FPG, Fasting Plasma Glucose; 2-h PG, Plasma Glucose two 
hours after oral glucose ingestion; HbA1c, glycated hemoglobin; HDL, high density lipoproteins; LDL, low 
density lipoproteins; TG, Triglycerides; HOMA-IR, homeostatic model assessment-insulin resistance; Data 
mean ± SEM. * p < 0.05, calculated using Student t-test. 
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Table 4: Anthropometric and Metabolic Characteristics of Healthy 
Volunteers  
 
  Paper 1 Paper 4 
  Pre-training Post-training Muscle strip donors 
n 13  8 
Sex (F/M) 7/6  0/8 
Age (y) 25 ± 3  53 ± 2 
Height (cm) 174  ± 10  181 ± 2 
Weight (kg) 70.0  ± 11.3 69.6  ± 10.5 82.4 ± 2.7 
BMI (kg/m2) 22.8  ± 2.2 22.7  ±  1.9 25.24 ± 0.6 
Waist to hip ratio   0.89 ± 0.02 0.89 ± 0.02 
Body fat % 24  ± 8 23 ± 8    
SBP (mmHg)    125 ± 5 
DBP (mmHg)    81 ± 3 
FBG (mmol/L)    5.3 ± 0.1 
Insulin (pmol/L)    36.9 ± 8.0 
HbA1c (%) 4.3 ± 0.3 4.2 ± 0.3* 5.4 ± 0.1 
HbA1c,mmol/mol    35.9 ± 0.6 
HDL (mmol/L) 1.2 ± 0.29 1.2 ± 0.23 1.4 ± 0.08 
LDL (mmol/L) 2.24 ± 0.54  2.17 ± 0.54 3.7 ± 0.2 
TG (mmol/L) 0.82 ± 0.34 0.67 ± 0.24 0.85 ± 0.14 
Total cholesterol, (mmol/L) 3.84 ± 0.65 3.67 ± 0.62 5.3 ± 0.3 
NGT, normal glucose tolerant subjects; T2D, type 2 diabetes subjects; BMI, Body Mass 
Index; SBP, Systolic Blood Pressure; DBP, Diastolic blood pressure; FPG, Fasting Plasma 
Glucose; 2-h PG, Plasma Glucose two hours after oral glucose ingestion; HbA1c, glycated 
hemoglobin; HDL, high density lipoproteins; LDL, low density lipoproteins; TG, 
Triglycerides; HOMA-IR, homeostatic model assessment-insulin resistance; Data mean ± 
SEM. * p < 0.05. 
 
Type 2 diabetic patients included in the studies had good control over their blood glucose 
based on the fact that their mean HbA1c was below 7%. LDL cholesterol was also lower in 
the diabetic subjects as compared to respective controls. Study participants were matched for 
many parameters. Nevertheless, a few parameters were not matching in all cohorts. In paper 
1 the groups are not matched for waist circumference, while in paper 4, NGTs and T2Ds 
were not matched for waist to hip ratio, suggesting that these type 2 diabetic patients have 
more abdominal fat than the controls. Abdominal fat has been associated with type 2 diabetes 
and cardiovascular disease (Smith 2015). Type 2 diabetic patients matched for BMI with 
normal glucose tolerant subjects (paper 1) or with a higher BMI (paper 4) than normal 
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glucose tolerant subjects are thus expected to have more abdominal fat. Fasting glucose and 
insulin concentration in plasma were higher in type 2 diabetic compared to control subjects as 
expected. 
 
 MOUSE COHORT 3.2
In paper 1 we used C57BL/6J and C57BL/6J-ob/ob mice. Although strain differences are 
widely recognized and have been studied (Kulkarni, Almind et al. 2003), C57BL/6J remain 
the most commonly used mouse strain. Mouse assembly and gene annotation are based on 
C57BL/6J genome. Their popularity makes it also suitable to compare and reproduce studies.  
 
 RAT COHORT 3.3
In paper 3 we used Wistar rats, a commonly used outbred albino rat, in two distinct 
experiments. In the first experiment we had two variables: diet (chow or high-fat) and 
exercise (sedentary rats or trained rats) thus finally resulting in 4 groups: Rats in the first 
group ate a chow diet and remained sedentary. In the second group, rats received also a chow 
diet but underwent training. In the third and fourth group, rats were fed a high-fat diet while 
rats in the third group remained sedentary and rats in the fourth group underwent training. 
Training consisted of swimming sessions of three hours separated by 45 minutes of rest each 
day for 5 days as described somewhere else (Galuska, Kotova et al. 2009).  
In the second experiment, no in vivo treatment was performed but tibialis anterior muscles 
from Wistar rats were collected for in vitro contraction performed as described in paper 3. In 
brief, rats were anesthetized and both tibialis anterior muscles were collected. One tibialis 
anterior muscle was then subjected to electrically-stimulated in vitro contraction for one hour 
while the other TA remained untouched. Muscles were then transferred to oxygenated buffer 
for four hours before snap freezing in liquid nitrogen. 
 
 CELL CULTURES 3.4
We used two major types of cells in culture: primary cells and immortalized cell lines. 
Immortalized cell lines are primary cells selected or engineered to evade senescence and can 
theoretically be grown for indefinite passages in vitro. Transformed cells usually proliferate 
rapidly and are quite resistant to external stressors. Primary cells are directly extracted from 
tissue. As tissues contain multiple sorts of cells, purification is a challenge. Once in culture in 
vitro, primary cells have a limited lifespan. After a certain number of cell divisions they stop 
proliferating or lose their ability to differentiate.  
In paper 1 and 3 we used well established mouse C2C12 and rat L6 cell lines purchased 
from ATCC (Manassas, VA, USA). In paper 4 we used primary human skeletal muscle cells 
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isolated in our laboratory from the “muscle strip donors” cohort described in Table 4. Not all 
isolations procedures were successful and some cultures had to be abandoned either because 
the cells would not grow, because macroscopic inspection revealed contamination with other 
cell types or because molecular markers specific for muscle cells were not expressed by the 
primary cells in culture. 
 
 mRNA EXPRESSION ANALYSIS 3.5
mRNA analysis in this thesis involved 4 steps: sample collection, mRNA extraction, reverse 
transcription of the RNA into cDNA and real-time quantitative PCR (qPCR). Clear 
guidelines for all these steps have been described (Bustin, Benes et al. 2009). Sample 
collection requires that the tissue or cells are immediately frozen or kept at 4°C and put into a 
protective lysis buffer to prevent RNA degradation before extraction. Trizol is the most 
widely used method for RNA extraction, but several commercial suppliers offer columns 
system for purification of RNA of all sizes or co-purification of RNA and DNA. We used 
TRIzol reagents (Thermo Fisher Scientific) to extract RNA from mouse muscle in paper1 
and column-based (from Qiagen) methods for all other extractions. Details are described in 
the respective papers. 
RNA concentration and purity has been assessed by measurement of absorbance properties of 
the sample using a spectrophotometer (Nanodrop 1000 from Thermo Fisher Scientific). Other 
methods have been described and compared (Bustin 2005).In paper 3, RNA integrity has 
been measured using the Experion Automated Electrophoresis System (Bio-Rad 
Laboratories, Hercules, CA). 
cDNA synthesis is easily performed using ready-made kits from commercial suppliers 
including random primers and protocols ensuring complete conversion of RNA into cDNA. 
cDNA is more stable than RNA and can be stored over long periods of time at -20°C. In all 
papers in this thesis the High-capacity cDNA RT Kit (Thermo Fisher Scientific) was used. 
Abundance of the transcript in the original sample is measured by increased fluorescence 
emission throughout a PCR reaction including most commonly either Taq-Man reagents or 
SYBR Green dye. Taq-Man polymerase and Taq-Man probes (Thermo Fisher Scientific) 
were used in paper 1. Taq-Man Probes purchased from Thermo Fisher Scientific are 
guaranteed to detect exclusively the gene of interest and to have 100% efficiency, meaning 
that every PCR cycle doubles the amount of cDNA of the target gene. Custom Taq-Man 
probes can also be designed. In papers 2, 3 and 4 we designed our own primers and 
performed the qPCR using SYBR Green dye. 
When designing our own primers, we evaluated specificity in sillico (through blasting using 
NCBI/ Primer-BLAST https://www.ncbi.nlm.nih.gov/tools/primer-blast/) and subsequently 
performed a melting curve to ensure that qPCR amplification was limited to one specific 
product. Self-designing primers is inexpensive and permits targeting specific splice variants. 
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As mRNA input for cDNA synthesis and qPCR is imprecise, a normalization step using 
housekeeper genes is necessary. A suitable housekeeper gene is not affected by the 
differences between groups or by the treatment. We usually assessed three or more potential 
housekeeper genes and using NormFinder (Pfaffl, Tichopad et al. 2004), selected the most 
suitable gene or combination of genes for normalization. The house keeping genes for each 
study are specified in the experimental details related to each paper.  
 
 IMMUNOBLOT ANALYSIS AND ANTIBODIES 3.6
Immunoblots were performed as described in the papers. Most antibodies used have been 
tested, validated and used in previous publications from our laboratory. New antibodies from 
Abcam (ab, Cambridge, UK),  Santa Cruz Biotechnology (sc-, Dallas, TX, USA) and Sigma-
Aldrich (sig, Saint-Louis, MO, USA) were tested for TWIST1(sig6451,sc-15393 and sc-
6269), TWIST2 (ab66031), SPRY1 (ab75492 and sc-30048), Nuclear Respiratory Factor 1( 
NRF1) (sc-721) and Early Growth Response 1 (EGR1) (sc-189). 
In paper 1, overexpression of Twist1 and Twist2 was examined using qPCR and metabolic 
assays. Immunoblotting confirmed overexpression of TWIST2 protein. Despite using 3 
different antibodies, we could not identify and measure TWIST1 protein as no band 
corresponded to the expected molecular weight or presented an overexpression pattern 
between samples. 
In paper 3, we tested 2 different antibodies to measure SPRY1 protein expression. In our 
setup, Abcam’s SPRY1 antibody (ab75492) bound to many unspecific sites and was 
discarded. Santa Cruz’s antibody (sc-30048) bound to 3 proteins in the vicinity of SPRY1 
expected molecular weight. HepG2 cells highly express SPRY1 and allowed us to identify 
the band corresponding to SPRY1. No difference in SPRY1 protein expression was noted 
between groups (see Figure 10 on page 32).  
Antibodies against NRF1 and EGR1 were used in a supershift assay in paper 3. These 
antibodies have been successfully used in supershift and chromatin immunoprecipitation 
(ChIP) assays for several years and by multiple research groups, however, the results we 
obtained were inconclusive and will require further optimization. 
 
 ELECTROPHORETIC MOBILITY SHIFT ASSAY AND SUPERSHIFT ASSAY 3.7
We used electrophoretic mobility shift assay (EMSA) to study protein-DNA interaction at the 
Spry1 promoter and assess if methylation of the promoter would enhance or prevent binding 
of skeletal muscle nuclear proteins. We adapted a previous protocol (Hellman and Fried 
2007) as detailed in the method section of paper 3. To methylate the probe we used CpG-
only Methyltransferase (M.SssI) (New England Biolabs, Ipswich, MA). To our surprise, 
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complete methylation of the CpGs in the probe resulted in increased binding of nuclear 
factors.  
 
Figure 5: EMSA: unmethylated unlabeled competitor (cold probe) in excess did not affect nuclear extract 
binding to the methylated labeled probe. 
In the search to identify which transcription factor/s bind to the methylated Spry1 promoter, 
we used FIMO version 4.11.0 (Grant, Bailey et al. 2011) to scan for individual motifs 
recognized by transcription factors. We used two different motif databases: 
JASPAR_CORE_2016_vertebrates and Uniprobe_mouse. There was unfortunately no 
available database specific for rats. From this analysis, we selected NRF1 as an interesting 
potential target as it has been linked to metabolism and growth (Cam, Balciunaite et al. 2004; 
van Tienen, Lindsey et al. 2010). When extending the sequence 24 bases away from the TSS 
of the gene, a motif recognize by EGF1 transcription factor was found. 
We performed a super-shift assay as described (Dhar and Wong-Riley 2009) with 
modifications stated in the methods of paper 3 , where we added either one of the antibodies 
or IgG as a control together with nuclear extract and labeled methylated probe. This should 
allow us to test if incubation with the specific antibody will bind with the transcription factor 
and result in a shift of the protein-DNA complex. However no such shift in binding was 
noticed as compared to the IgG control lane. 
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 BISULFITE CONVERSION 3.8
Sequencing techniques do not discriminate between a cytosine and a methylated cytosine. 
Bisulfite treatment of DNA samples transforms unmethylated cytosines into uracil while 
methylated cytosines remain unaltered (Figure 6). Subsequent PCR amplifies the target 
region while tyrosine is incorporated in lieu of uracils which represent also the unmethylated 
cytosine of the original sequence (Figure 7). Complete bisulfite conversion without DNA 
breakdown is a challenge. Commercially available kits have been developed and optimized 
for this purpose. We tested both EpiTect Fast Bisulfite Conversion Kit (Qiagen) and EZ DNA 
Methylation-Gold Kit (Zymo research, Ivrine, CA) and both performed equally well. 
Pyrosequencing controls for complete bisulfite conversion by testing a random CpH 
(meaning a non-CpG site), supposed unmethylated in the original DNA sequence, for 
complete conversion into thymidine during the sequencing step. 
 
 
Figure 6: Bisulfite-mediated conversion of cytosine to uracil. 
(Image under CC0 1.0 Universal Public Domain Dedication). 
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Figure 7: Base substitution during bisulfite conversion and PCR amplification before pyrosequencing. 
A: Adenosine; C: Cytosine; T: Thymidine; G: Guanine; CH3: methyl-group. 
 
 PYROSEQUENCING 3.9
Pyrosequencing is a method used for de novo sequencing and, when combined with bisulfite 
treatment, to determine methylation status of short regions of DNA. Pyrosequencing was 
performed as described in papers 3 and 4. The challenge we encountered with 
pyrosequencing was to design primers that would successfully amplify and sequence our 
target region. Caveats in the design were CpG density and repetitive motifs. If the density of 
the CpG is high, there will be expected changes in the sequence due to the bisulfite 
conversion step. Because of the density, primers will overlap with CpGs and binding might 
not be effective or biased. In case of a repetitive sequence, primers might bind at several 
locations resulting in amplification of several products. These multiple products will be 
detected during the electrophoresis step. About 25% of our primer’s designs resulted in 
successful sequencing. Once the primers are established, Pyrsequencing is a straightforward 
technique as described in handbooks.  
 
 STATISTICAL ANALYSIS 3.10
Data in the studies are presented as mean ± SEM. Student’s t-test and paired- Student’s t-test 
were used to compare two groups. Repeated measures one-way ANOVA followed by 
Bonferroni’s multiple comparisons test was used to compare two groups across multiple time 
points. Two-way ANOVA followed by Bonferroni’s multiple comparisons test was used in 
experiments with more than two groups. Pearson’s correlation coefficient was used to 
analyze the relationship between two variables. 
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4 RESULTS AND DISCUSSION 
 
 TWIST PROTEIN IN SKELETAL MUSCLE 4.1
Type 2 diabetes and obesity are characterized by low-grade inflammation. Several pro-
inflammatory cytokines are up-regulated in the insulin resistant state including Tumor 
necrosis factor (TNFα) and Interleukin 6 (IL6) (Donath and Shoelson 2011). On the contrary, 
exercise training is known to have long-term anti-inflammatory effects (Woods, Vieira et al. 
2006). IL6, a cytokine upregulated by exercise and in type 2 diabetes, appears to have 
differential effects whether acting on the liver, adipose tissue or in skeletal muscle (Castanon, 
Von Stetina et al. 2001; Glund and Krook 2008). Transcription factors regulate the gene 
expression of multiple targets, thus affecting cell function. TWIST proteins play a role in 
metabolism and inflammation as Twist1 silencing reduces fatty acid oxidation and modulates 
pro-inflammatory cytokine expression and secretion in adipose tissue (Pettersson, 
Laurencikiene et al. 2010; Pettersson, Mejhert et al. 2011). We hypothesized that TWIST1 or 
TWIST2 would play a role in metabolic disease and cellular process within skeletal muscle. 
In paper 1 we studied Twist1 and Twist2 overexpression in myoblasts in vitro and in the 
tibialis anterior skeletal muscle of mice in vivo. We found that overexpressing Twist 1 or 
Twist 2 in skeletal muscle had profound effects on mRNA expression and protein abundance 
of genes related to inflammation and energy metabolism in skeletal muscle. We found signs 
of glycolysis enhancement: increased Akt signaling was accompanied by decreased Pdk4 
mRNA expression, reduced Acetyl-CoA carboxylase (ACC) and glycogen synthase (GS) 
protein expression and decreased glycogen stores (Figure 8). Moreover, mRNA expression 
of the inflammatory markers Il1β, Il6, and TNFα was upregulated. 
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Figure 8: Twist1 or Twist2 overexpression increases protein kinase B (Akt) signaling while inhibiting 
acetyl-CoA carboxylase (ACC) and glycogen synthase (GS), thus promoting energy expenditure and 
cell growth 
 
While we focused on the role of the TWIST proteins in glucose utilization and glycogen 
stores, the important role of TWIST1 in skeletal muscle development should not be 
overlooked. As TWIST1 is a known inhibitor of MyoD and could reverse myogenesis 
(Hjiantoniou, Anayasa et al. 2008), we used C2C12 myoblasts and not myotubes. 
Furthermore, the plasmid we used could not be efficiently transfected into dividing skeletal 
muscle cells, while it was well incorporated into myoblast cultures. To verify the potential 
effects of TWIST1 and 2 on differentiation, we measured mRNA expression of MyoD, Pax7, 
and myogenin in cells and tibialis anterior muscle. Only myoblasts with Twist1 
overexpression presented an increase in Pax7 mRNA expression, but at the same time MyoD 
and myogenin trended to be up-regulated, highlighting the role of TWIST1, but not TWIST2 
in skeletal muscle differentiation. These changes were not visible in tibialis anterior muscle 
overexpressing Twist1, suggesting that differentiated cells in vivo might have counter-
mechanisms against TWIST1-induced de-differentiation. 
A limitation in the interpretation of our results is that we overexpress Twist1 or Twist2 
mRNA by more than 3 fold. As TWIST proteins are basic helix-loop-helix proteins, a dose-
response experiment could potentially reveal contrasting effects depending on the magnitude 
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of the overexpression. TWIST protein concentration probably impacts dimers formation, 
partner protein availability for dimerization and consequently, downstream effects. 
We further measured Twist 1 and 2 mRNA expression in different metabolic states: obese and 
diabetic ob/ob mice, healthy and diabetic humans and in skeletal muscle biopsies obtained 
before and after exercise training. We found no difference in Twist 1 and 2 mRNA expression 
in these various metabolic states. mRNA expression does not always reflect protein 
abundance and activity. Nevertheless, our results suggest that despite being expressed in 
skeletal muscle, Twist1 and 2 might not be altered by these metabolic conditions. This 
conclusion does not preclude TWIST proteins to be of potential benefit in metabolic diseases. 
We focused on overexpression of the Twist genes as previous reports suggested that TWIST1 
was not expressed in mammalian skeletal muscle (Pettersson, Laurencikiene et al. 2010). 
However, using different sets of Taq-Man primers, we showed that TWIST1 and TWIST2 
mRNA is present in mouse and human skeletal muscle. As overexpression of the Twist genes 
increases inflammatory and glycolysis markers, silencing their expression could be beneficial 
to reduce inflammation and increase fatty acid oxidation. 
 
 THE KYNURENINE PATHWAY AND ACUTE EXERCISE 4.2
KATs are enzymes expressed in skeletal muscle and several other tissues where they convert, 
among other substrates, kynurenine into kynurenic acid (Perkins and Stone 1982; Han, Cai et 
al. 2010). This conversion prevents kynurenine from reaching the brain as kynurenic acid 
cannot cross the brain blood barrier, thus reducing the risk of depression (Myint, Kim et al. 
2007; Oxenkrug 2010; Agudelo, Femenia et al. 2014; Campbell, Charych et al. 2014). 
Exercise training and PGC1α-induced increases in skeletal muscle KAT expression have 
been linked to decreased circulating kynurenine levels and resistance to stress-induced 
depression (Agudelo, Femenia et al. 2014). We tested the hypothesis that acute exercise in 
humans is sufficient to impact circulating kynurenine levels, and asked whether type 2 
diabetic patients would respond to the same extent as healthy volunteers. 
In paper 2 we observed that acute exercise alters kynurenine levels in plasma. Plasma 
tryptophan and kynurenine concentrations were reduced, while kynurenic acid levels 
increased. Our results are consistent with earlier evidence that exercise or increased PGC1α 
expression are associated with enhanced conversion of kynurenine into kynurenic acid 
(Agudelo, Femenia et al. 2014). Changes in the kynurenine pathway noted in response to 
exercise were similar between type 2 diabetic and healthy volunteers, suggesting that this 
mechanism is preserved in people with type 2 diabetes. 
We also correlated metabolite concentrations at baseline and three hours after the exercise 
bout with clinical parameters. Kynurenine levels correlated with BMI regardless of diabetes. 
As obesity has been linked to depression (Mannan, Mamun et al. 2016; Muhlig, Antel et al. 
2016), elevated kynurenine levels may play a role in obesity-related depression. However, we 
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did not have mood or depression rating scales to measure possible acute changes of mood in 
this cohort. 
In our study we noticed that plasma tryptophan was 10 times more concentrated than 
kynurenine, which is 1,000 times more concentrated than kynurenic acid. After acute 
exercise, both tryptophan and kynurenine plasma concentrations were reduced by 20-30%, 
while kynurenic acid was increased by 15%. Thus the increase in kynurenic acid does not 
fully explain the decrease in tryptophan and kynurenine. These decreases could be explained 
by a shunt of tryptophan conversion from kynurenine to serotonin, thus reversing a major 
etiological process in depression (Lapin and Oxenkrug 1969). However, we did not have 
assays to measure serotonin and the other arm of the kynurenine pathway, quinolinic acid and 
intermediary products. Assessment of these species would be informative and should be 
performed in future studies.  
The low plasma concentration of kynurenic acid could be partly explained by the fact that 
kynurenic acid is an acid and therefore does not easily diffuse through a phospholipid bilayer 
such as the plasma membrane (Cooper 2000). Although kynurenic acid transporters have 
been described (Uwai, Hara et al. 2013), they do not appear to be expressed in skeletal 
muscle (according to the human protein atlas accessed on August 18th 2016 (Uhlen, 
Fagerberg et al. 2015). 
In paper 2, KATs expression measurements revealed that three hours after an acute bout of 
exercise KATs 1,2 and 3 mRNA was unaffected, while KAT4 mRNA decreased. Absence of 
an increase in KATs mRNA expression is in contrast to previous results in mice where Kats 
1,3 and 4 mRNA expression was increased after 8 weeks of voluntary wheel running 
(Agudelo, Femenia et al. 2014). This discrepancy could be due to several factors. KATs 
mRNA induction may require more than three hours or may require several bouts of exercise 
as observed for the expression of other genes (Yang, Creer et al. 2005). As plasma 
concentration of the metabolites is already altered after an acute bout of exercise, it is 
probable that the activity of the KATs enzymes in skeletal muscle or other peripheral tissues 
is already increased by acute exercise. Type 2 diabetic volunteers exhibited reduced levels of 
KAT1 and KAT2 mRNA compared to their healthy counterparts without any measurable 
consequence on plasma concentration of kynurenine or kynurenic acid suggesting that 
mRNA might not reflect protein level or enzymatic activity. 
The clinical setup has some limitations. Resting blood chemistry and biopsy were taken after 
an overnight fast on a different day than the samples taken immediately after the acute bout 
of exercise and after a three hours recovery period. Furthermore, volunteers had a light 
breakfast on the day of the exercise bout. These variables add confounding factors for the 
time course study, but are likely not sufficient to explain the differences seen between rest, 
exercise or recovery. Especially, kynurenic acid concentration was increased by exercise, but 
was similar between rest and recovery. 
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To monitor exercise intensity, we used maximum heart. .Heart rate is a simple measure, but 
with some drawbacks. Intensity measured by VO2 or energy output in watts is stable 
throughout the exercise bout and reproducible to a certain extent between bouts. Heart rate on 
the contrary is influenced by multiple, rapidly changing, factors such as fever, fatigue or 
hydration. During the exercise, heart rate is not stable. If intensity is maintained, heart rate 
will increases over time. This phenomenon is known as “cardiac drift” and is especially 
prominent if, as in our design, hydration is not provided (Coyle and Gonzalez-Alonso 2001).  
Thus, using heart rate as a measure of exercise intensity may have resulted in reduced 
exercise intensity. Nevertheless, the exercise bout was sufficient to induce changes in 
tryptophan, kynurenine and kynurenic acid plasma concentration. 
Despite the limitations mentioned, our study sheds light on the effects of acute exercise on 
the kynurenine pathway and provides a potential mechanism for the anti-depressive effects of 
exercise. Interestingly, exercise-mediated changes in kynurenine metabolism are preserved in 
type 2 diabetic patients, highlighting the therapeutic potential of exercise in this population. 
 
 DNA METHYLATION IN SKELETAL MUSCLE 4.3
In skeletal muscle, DNA methylation has been shown to respond to and be modulated by 
multiple stimuli including exercise, diabetes and diet (Barres, Osler et al. 2009; Barres, Yan 
et al. 2012; Nitert, Dayeh et al. 2012; Lindholm, Marabita et al. 2014). For selected genes, 
these studies have suggested a possible role of DNA methylation in cell metabolism by 
drawing positive or negative correlations with mRNA expression or protein abundance. 
 
4.3.1 Exercise, Diet and DNA Methylation 
The multiple health benefits of physical activity and exercise training are the result of 
repeated skeletal muscle contraction, but also involve and impact most organs and tissues in 
the body. The health benefits of regular physical activity include but are not limited to, a 
reduction of relative risk of dementia, diabetes, depression, hip fracture and several cancers 
including breast and colon cancer (Rethorst, Wipfli et al. 2009; Khan, Thompson et al. 2012). 
Understanding which exercise-mediated changes are driving health benefits is an area of 
active research. In this thesis, the effects of exercise are studied in three out of four studies. 
As the lack of exercise and an unhealthy diet are important factors in the development of 
obesity and type 2 diabetes, we used four different cohorts in paper 3: The first cohort was 
composed of sedentary rats on a chow diet as controls, the second of rats trained by 
swimming for 5 days, the third of sedentary rats fed a high-fat diet, the fourth of both trained 
and fed rats (Figure 9). Molecular markers of exercise response and high-fat feeding had 
already been assessed in another study (Galuska, Kotova et al. 2009). We assessed the effects 
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of exercise training on DNA methylation. We hypothesized that exercise-mediated changes in 
skeletal muscle mRNA would in part be dependent on altered DNA methylation. 
 
Figure 9: Design of the Rat Cohorts study in paper 3. A: Design of the timeline. B: Design of the groups 
and treatments. 
 
Using methylated DNA immunoprecipitation sequencing (MeDIP-sequencing) we revealed 
genome-wide differences in the DNA methylation profile induced by exercise, before 
validating some specific targets at base-pair resolution in all four groups. DNA methylation 
changes were not accompanied by changes in mRNA or protein levels of nearby genes 
(Figure 10), raising the question discussed later in this thesis of the physiological 
consequences of the methylation changes in these specific targets. 
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Figure 10: SPRY1 immunoblot. 
CS: chow fed & sedentary rats; CT: Chow fed & trained rats; HS: high-fat fed & sedentary rats; HT: high-fat 
fed & trained rats. Results are presented as individual values and mean ± SEM arbitrary units.  
In studies investigating human skeletal muscle DNA methylation in a metabolic context, 
DNA methylation changes affected only a limited percentage of all the cells in the samples, 
raising the question of the significance and of the origin of the cells affected (Barres, Osler et 
al. 2009; Barres, Yan et al. 2012; Nitert, Dayeh et al. 2012; Lindholm, Marabita et al. 
2014).For example, is only one cell type affected or a sub-group of multiple cell types? Is it a 
fiber type specific matter? DNA methylation changes could be due to changes in the 
composition of the muscle as satellite cells start proliferating and new nuclei are added in the 
case of muscle growth. With training, vascularization of the muscle changes (Gustafsson 
2011), possibly altering the DNA methylation profile of a whole-muscle biopsy. Cellular 
composition of the biopsy subjected to DNA methylation profiling may also reflect changes 
in cell type due to neutrophil infiltration following exercise (Schneider and Tiidus 2007). 
Contamination of the biopsy by vascular or subcutaneous fat tissue during the surgical 
procedure is another possible confounding factor. 
In paper 3 we used several methods in attempt to unravel the origin of the DNA methylation 
changes. In recent studies on skeletal muscle DNA methylation and exercise performed in our 
laboratory and by others, the differences in methylation between groups were subtle (Barres, 
Yan et al. 2012; Nitert, Dayeh et al. 2012; Lindholm, Marabita et al. 2014). Satellite cells 
represent approximately 8% of the nuclei of a skeletal muscle, while the rest is half 
myonuclei and half stromal nuclei (Schmalbruch and Hellhammer 1977). We hypothesized 
that DNA methylation changes observed after exercise could be due to satellite cells being 
reprogrammed into myoblasts and later on into differentiated myotubes. 
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DNA sequences in the promoter region of Spry1, a regulator of satellite cell quiescence, 
presented DNA methylation changes resulting from both training and diet interventions. 
EMSA analysis revealed that nuclear proteins bind to this Spry1 promoter region when CpGs 
are fully methylated. We attempted to perform a supershift assay using antibodies against two 
transcription factors possibly binding around that region, but no changes in binding were 
noted. To further test the hypothesis that the DNA methylation could be related to changes in 
satellite cell proliferation and differentiation, we examined the DNA methylation profile of 
the Spry1 promoter between proliferating and differentiated L6 myotubes. No changes in 
DNA methylation were noted, suggesting that changes in DNA methylation of the Spry1 
promoter are not linked to differentiation of myoblasts in vitro. However, differences in the 
DNA methylation landscape between cells in vivo and in vitro have been noted (Nestor, 
Ottaviano et al. 2015). Further experiments isolating satellite cells and skeletal muscle fibers 
in vivo would be needed to address this more fully. Moreover, DNA methylation of Spry1 
could be measured at several time points during differentiation, as changes are possibly 
transient during the process of differentiation. 
Subtle differences in DNA methylation could be explained by factors extrinsic to skeletal 
muscle or changes in the cellular composition of the skeletal muscle rather than changes in 
the epigenome of the myonuclei. To explore this hypothesis, we isolated tibialis anterior 
muscles from rats and subjected them to in vitro contraction followed by four hours of 
recovery. There was no difference in DNA methylation between contracted and control 
muscles suggesting that an external factor or “crosstalk” between skeletal muscle and other 
organs might be necessary to induce the DNA methylation changes observed in Spry1. 
However, such extrinsic factors appear not always necessary, as a previous study from our 
research group highlighted cases where similar DNA methylation changes were induced by 
exercise in a human cohort, as by in vitro contraction in mouse skeletal muscle but only 45 
minutes after the end of the contraction protocol and not at other time points (Barres, Yan et 
al. 2012). Nevertheless, a biopsy after training and in vitro contraction are two different 
models and many variables can account for differences between experimental results. For 
example, we did not mimic the five days training protocol: the in vitro contraction protocol 
was only sustained for one hour and the muscle specimen had four hours recovery following 
the exercise. 
4.3.2 Insulin and DNA Methylation in Skeletal Muscle 
In paper 4 we assessed if insulin triggers epigenetic modifications in skeletal muscle. Using 
the 450k DNA methylation array, a genome-wide technique, we revealed that a one hour 
insulin treatment of human skeletal muscle in vitro induces broad changes in the DNA 
methylation profile. A genome wide approach allowed us to subsequently investigate 
expected targets (HK1 and HDAC5), as well as potentially novel targets of insulin (DAPK3 
and ATP2A3). Base pair resolution pyrosequencing confirmed insulin-induced increase in 
DNA methylation in the gene body of DAPK3 at one specific CpG and the changes in the 
3’UTR region of ATP2A3 at two different CpGs. To further validate these results, we 
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exposed primary human myotubes to insulin in vitro and observed a trend in increased 
DAPK3 methylation mirroring the result observed in the biopsies. 
To translate our results to an in vivo setting, skeletal muscle DNA methylation was also 
assessed in biopsies obtained from normal glucose tolerant and type 2 diabetes subjects 
(Table 3) before and after an oral glucose challenge. DAPK3 methylation was reduced in 
skeletal muscle from type 2 diabetic patients as compared to controls at baseline, and a 
glucose challenge further decreased DAPK3 DNA methylation in both groups. 
Hyperglycemia and loss of insulin sensitivity have additive effects on skeletal muscle DNA 
methylation in human skeletal muscles, but the difference in DAPK3 DNA methylation 
between the insulin- and glucose-stimulated conditions is difficult to reconcile as both of 
these factors induce insulin resistance. Additional systemic factors induced by hyperglycemia 
probably affect DAPK3 DNA methylation. Furthermore, DAPK3 DNA methylation was 
inversely correlated with plasma glucose concentration two hours after the glucose challenge, 
thus potentially involving DAPK3 in nutrient signaling pathways. 
Further experiments in myocyte cultures in vitro could help separate the direct roles of 
glucose and insulin on skeletal muscle DNA methylation. Furthermore, measurement of the 
skeletal muscle mRNA expression of DAPK3 between type 2 diabetic and normal glucose 
tolerant subjects is lacking. 
Basal DAPK3 methylation was lower in the muscle strips than in biopsies from control 
subjects before the glucose challenge. Differences in methylation could be due to the 
different techniques used to collect the biopsies, differences in clinical parameters between 
the cohorts such as age, or to the fact that muscle strips are not flash frozen in liquid nitrogen 
but transported to the laboratory before incubation. During transport and incubation, a 
possible hypoxia could induce changes in the DNA methylation profile. This possibility 
could be assessed by measuring DNA methylation in strips frozen immediately after 
collection. Furthermore, the type 2 diabetic and normal glucose tolerant volunteers included 
in this study presented differences in BMI that may also explain the differences observed in 
the DNA methylation. However, blood glucose levels were more tightly correlated with DNA 
methylation than BMI, thus glucose levels are more likely to explain changes in DNA 
methylation of DAPK3.  
In vitro insulin stimulation of skeletal muscle strips did not correlate with mRNA changes of 
DAPK3 or ATP2A3 after one hour of insulin stimulation. As most mRNA expression changes 
following insulin stimulation in skeletal muscle appear after three hours of stimulation 
(Pandini, Medico et al. 2003; Rome, Clement et al. 2003), we stimulated myotubes in vitro 
and collected DNA and mRNA four hours after the insulin stimulation. We found that 
DAPK3 and ATP2A3 mRNA was unaltered four hours after insulin treatment, while DNA 
methylation only trended to be altered by the insulin stimulation. A larger number of subjects 
would be necessary to be able to conclude these observations more firmly. 
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4.3.3 DNA Methylation and Gene Expression 
The addition of a methyl group to a cytosine is commonly considered as a modification that 
will repel transcription factor binding, thus making DNA methylation a repressive mark. 
However, DNA methylation can also lead to increased transcription factor binding (Rishi, 
Bhattacharya et al. 2010). In paper 3, methylation of the Spry1 promoter increases skeletal 
muscle nuclear factor binding to the promoter. 
Promoter hypermethylation correlating with gene silencing or promoter demethylation 
leading to de-repression of mitogenic genes is a well-known phenomenon in cancerous cells 
(Jones and Baylin 2002). In vitro studies using luciferase assays comparing gene expression 
relative to promoter methylation have often demonstrated that complete methylation of all 
CpG in the promoter leads to reduced expression of the gene (Yang, Dayeh et al. 2012; Ronn, 
Volkov et al. 2013). Nevertheless, some hypermethylated promoters are transcriptionally 
active, while unmethylated promoters can be inactive (Boyes and Bird 1992; Weber, 
Hellmann et al. 2007). Recent genome-scale studies found negative associations, positive 
associations or no association between DNA methylation and gene expression (Eckhardt, 
Lewin et al. 2006; Ball, Li et al. 2009; Lister, Pelizzola et al. 2009). Overall, epigenetic 
studies in the field of metabolism found that a minor proportion of the regions with altered 
DNA methylation also exhibited differential mRNA expression (Jacobsen, Brons et al. 2012; 
Nitert, Dayeh et al. 2012; Ronn, Volkov et al. 2013; Lindholm, Marabita et al. 2014). In 
paper 3 and 4 we did not find correlation between DNA methylation changes and gene 
expression, suggesting that other factors such as histone modifications and CpG density 
(Weber, Hellmann et al. 2007) influence the expression of the genes we investigated in these 
studies. DNA methylation in the regions we studied could potentially alter expression of 
distant genes in a similar fashion as the FTO variant influences expression of the distant 
IRX3 gene (Smemo, Tena et al. 2014). Studying other epigenetic mechanisms in insulin- or 
exercise-treated samples as described in paper 3 and 4 could help understanding the 
interplay between the multiple layers of epigenetic regulation and gene expression. 
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Figure 11: Schematic Summary of the Main Resuls from Papers 3 and 4: Stimuli affect skeletal muscle 
signaling and epigenetic marks, which in turn affect the cellular program. (Muscle schemative adapted from 
Servier Medical Art) 
 
4.3.4 Techniques in DNA Methylation Studies 
In this thesis, paper 3 and 4 aim to understand how DNA methylation participates in the 
adaption of skeletal muscle to exercise training and diet and how hormonal signaling by 
insulin may influence these responses. We used whole genome MeDIP-sequencing and 
genome wide human 450k methylation array followed by pyrosequencing to measure 
changes in DNA methylation of skeletal muscle. 
Several genome-wide methods have been recently developed to study DNA methylation on a 
large scale. Several reviews have described and compared methods (Bock, Tomazou et al. 
2010; Laird 2010; Nair, Coolen et al. 2011; Walker, Bhagwate et al. 2015). The cutting edge 
techniques in 2012-2013 were: methylated DNA immunoprecipitation sequencing (MeDIP-
sequencing), DNA capture by affinity purification (MethylCap-sequencing), reduced 
representation bisulfite sequencing (RRBS), and Human Methylation 450 Bead Chip (450k 
array). Whole genome bisulfite sequencing was, at the time, very costly and bioinformatics 
tools were not available. 
The 450k array is an affordable and reliable way to assess genome-wide DNA methylation at 
over 485’000 selected human CpG sites covering 99% of the human RefSeq genes with 
multiple sites per gene. With a cost of approximately 1500 SEK (200 US dollars) per sample 
the 450k array is now considered an excellent choice to study DNA methylation in large 
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groups. The 450k array was our method of choice in paper 4. In paper 3, as we studied rats, 
we had to find a different assay. 
MethylCap-sequencing more accurately identifies differentially methylate regions (DMRs) 
than MeDIP-sequencing (Bock, Tomazou et al. 2010), but has a lower sensitivity than 
MeDIP-sequencing in lowly methylated regions (Nair, Coolen et al. 2011). MethylCap-
sequencing was not the appropriate method for our project because promoter and gene bodies 
of expressed genes are usually lowly methylated. 
MeDIP-sequencing provides whole-genome coverage but relies on antibodies and thus 
depends on the affinity of the antibodies. MeDIP-sequencing is considered a qualitative rather 
than quantitative method as it is not totally accurate and reproducible (Bock, Tomazou et al. 
2010). RRBS uses the combination of restriction enzymes and bisulfite sequencing to enrich 
for areas with high CpG density and provide reliable data at a base-pair resolution (Bock, 
Tomazou et al. 2010). RRBS coverage is however limited. We selected MeDIP-sequencing 
for a broader coverage. Given that DNA methylation alterations between metabolic 
conditions are subtle, RRBS would probably have detected more DMRs. 
Genome-wide analyses provide a large amount of data requiring further bioinformatic 
analysis. Multiple tools are available: commercial all-in-one solutions like Ingenuity IPA, 
free packages for “R” or online tools such as DAVID (Database for Annotation, Visualization 
and Integrated Discovery) or Webgestalt. We mainly used Webgestalt as it is a published and 
freely available tool. Pathway analysis in Webgestalt is based on the Kyoto encyclopedia of 
genes and genomes (KEGG). Based on analysis from the sequencing companies and the one 
we performed in-house, we selected DNA regions to be technically validated on a base-pair 
resolution using pyrosequencing. 
Pyrosequencing is a method where bisulfite-converted DNA is amplified by polymerase 
chain reaction (PCR) and then sequenced to determine if the bases of interest were 
methylated or not (Tost and Gut 2007). It requires the design of a primer pair for PCR and a 
sequencing primer. Out of all the regions we aimed to investigate, many could not be 
sequenced as either the PCR or the sequencing failed due to problem in primer binding. 
When amplification and sequencing are successful, pyrosequencing is a precise tool to 
measure DNA methylation at base-pair resolution. 
We used pyrosequencing in papers 3 and 4. Interestingly, DNA methylation of Spry1 and 
Myh7b in gastrocnemius and tibialis anterior muscles from Wistar rats presented a very 
similar profile, illustrating that DNA methylation is stable between animal species and across 
muscle biopsies (Figures 12 and 13). On the contrary, in paper 4, DNA methylation in 
DAPK3 of in vitro skeletal muscle at basal is more variable between donors than the 
magnitude of the changes induced by the insulin treatment (Figure 14). More pronounced 
inter-individual differences in vitro may reflect DNA methylation profile changes induced by 
cell culture in vitro (Nestor, Ottaviano et al. 2015). Further experimental parameters such as 
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the purity of the cell culture or the multiplicity of stages of satellite cells differentiation could 
also account for inter-individual differences. 
 
 
Figure 12: Comparison of Myh7b DNA methylation from 3 different origins. 
A: From Rat gastrocnemius muscle; B: From rat tibialis anterior muscle C: from L6 rat muscle cell line. Data 
are presented as the mean ± SEM. * p<0.05, for exercise effect within one single CpG, ° p<0.05, for an 
interaction between exercise and diet within one single CpG. 
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Figure 13: Comparison of Spry1 DNA methylation from 3 different origins. 
A: From Rat gastrocnemius muscle; B: From rat tibialis anterior muscle C: from L6 rat muscle cell line. Data 
are presented as the mean ± SEM. * p<0.05, for exercise effect within one single CpG, ^ p<0.05, for diet 
effect within one single CpG. ° p<0.05, for an interaction between exercise and diet within one single CpG. 
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Figure 14: Individual changes in DNA methylation of DAPK3 at CpG1 at Basal, after insulin treatment 
and four hours after insulin treatment. Data are presented as percentage of DNA copies methylated (A) or 
relatively to the basal level (B). Each dot represents a subject at a specific time point. DNA methylation of 
DAPK3 and ATP2A3 varied between donors, while absolute changes in response to insulin treatment were 
more consistent. 
 
4.3.5 Approaches to Study Skeletal Muscle Methylation in Different 
Metabolic States 
In papers 3 and 4 we used a similar approach to compare DNA methylation in various 
metabolic contexts. In both cases we started with a genome-wide method comparing two 
conditions (sedentary and trained in paper 3, insulin stimulated or not in paper 4). We then 
used this data to target more specific regions. When target regions had been confirmed, we 
used other samples to assess the reproducibility of the findings in similar but different models 
(Figure 15). 
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Figure 155: Schematic of the systematic approach used in papers 3 and 4 
For example, the majority of mRNA transcripts regulated by insulin are significantly altered 
no earlier than three hours after insulin stimulation (Pandini, Medico et al. 2003; Rome, 
Clement et al. 2003). As we did not find mRNA changes in the genes of interest in the 
skeletal muscle strips after a one hour of in vitro stimulation, we used primary cell culture to 
assess if DAPK3 and ATP2A3 mRNA changes would appear four hours after the stimulation, 
as in the case of PDK4. The insulin treatment was effective as exemplified by the insulin-
responsive gene PDK4 (Figure 16), but neither DAPK3 nor ATP2A3 gene expression was 
affected. 
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Figure 166: mRNa expression of PDK4, DAPK3 and ATP2A3 in primary skeletal myotubes. Samples 
were collected at basal (white bar), immediately after one hour of insulin stimulation (grey bar) or incubated 
with insulin and collected four hours after stimulation (black bars). Data are mean ± SEM. *p<0.05, Basal vs 
four hours post-stimulation. 
 
In papers 3 and 4 we did not find any correlation between the changes in DNA methylation 
and mRNA expression. Depending on the gene, mRNA changes can occur up to 4 days after 
the last bout of exercise (Neubauer, Sabapathy et al. 2014). It is possible that we missed the 
correct window to capture changes in mRNA. Nevertheless, we tested whether methylation 
of the Spry1 promoter would alter binding of transcription factors to its sequence. 
Surprisingly, while methylation is usually associated to transcription factor binding 
inhibition, EMSA showed that methylation of Spry1 promoter increased its binding of 
nuclear proteins.  
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5 CONCLUSION 
 
The main findings in this thesis are: 
1. TWIST1 and TWIST2 proteins alter skeletal muscle glucose metabolism and mRNA 
transcription of cytokines. Skeletal muscle TWIST1 and TWIST2 mRNA expression is 
not altered in a range of metabolic conditions. 
 
2. Acute exercise alters plasma concentration of tryptophan, kynurenine and kynurenic 
acid in normal glucose tolerant healthy volunteers, as well as in type 2 diabetic 
subjects. Kynurenine concentration in plasma correlates with BMI in both healthy 
volunteers and type 2 diabetic subjects. 
 
3. Exercise training and diet alter the methylome in skeletal muscle. DNA methylation 
does not necessarily shown an inverse correlation with mRNA. DNA methylation 
increases binding of nuclear proteins to Spry1 promoter. 
 
4. Insulin stimulation acutely alters DNA methylation in skeletal muscle. Skeletal 
muscle DAPK3 DNA methylation is altered in type 2 diabetic patients. A glucose 
challenge reduces skeletal muscle DAPK3 DNA methylation in both normal glucose 
tolerant healthy volunteers and type 2 diabetic patients . 
 
Type 2 diabetes, obesity and exercise, all have profound effects on skeletal muscle gene 
expression and metabolism. The work included in this thesis reveals the metabolic effects of 
TWIST1 and TWIST2 overexpression in skeletal muscle; provides evidence for the acute 
effect of exercise on the kynurenine pathway and maps changes in the methylome following 
exercise training and insulin stimulation supporting the notion that DNA methylation is a 
rapidly adaptive epigenetic mark in somatic cells. Our studies further suggest the kynurenine 
pathway as a potential mechanism for some of the anti-depressive effects of exercise, and 
highlights glucose as a potential modulator of DNA methylation. 
Our work on DNA methylation in particular regions of the genome underscores recent results 
from genome-wide studies (Jacobsen, Brons et al. 2012; Nitert, Dayeh et al. 2012; Ronn, 
Volkov et al. 2013; Lindholm, Marabita et al. 2014) that  methylation often does not correlate 
with gene expression of the neighboring gene. However, DNA methylation increases nuclear 
protein binding as in the Spry1 promoter,  
Altogether, the work in this thesis reveals new mechanisms involved in the protective effect 
of exercise and the pathophysiology of type 2 diabetes and obesity, offering new 
opportunities for improvements in the management and treatment of metabolic diseases. 
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6 FUTURE PERSPECTIVES 
 THE TWIST PROTEINS 6.1
Work in this thesis confirms that TWIST1 and TWIST2 are expressed and play a role in 
skeletal muscle metabolism, growth and differentiation. Although we did not find alterations 
in TWIST mRNA in trained or type 2 diabetic people and obese mice, protein abundance and 
functional activity of TWIST proteins was not measured. Additionally, a map of DNA 
binding regions for TWIST by chromatin immunoprecipitation (ChIP) with DNA sequencing 
and a better understanding of TWIST dimerization and protein-protein interaction using 
Cross-linking/mass spectrometry would help refine understanding of the role of TWIST in 
skeletal muscle. Furthermore, TWIST1 and TWIST2 gene silencing studies could reveal 
beneficial effects in reducing inflammation and favoring fatty acid oxidation. 
 
 THE KYNURENINE PATHWAY 6.2
The kynurenine pathway has been linked to psychiatric disorders. Exercise reduces the risks 
of depression, possibly through the kynurenine pathway in mice, healthy humans and as 
described here, in type 2 diabetic subjects. Studying depressed subjects undergoing exercise 
training would allow direct correlation of depression score with tryptophan, kynurenine and 
other metabolites plasma concentration. Furthermore, the measurement of other metabolites 
such as quinolinic acid would broaden our understanding of the pathway equilibrium. 
Understanding the regulation of the balance between the transformation of tryptophan into 
kynurenine or serotonin and further, the transformation of kynurenine into kynurenic acid and 
quinolinic acid could increase our understanding of the role of tryptophan and kynurenine 
metabolism in depression. So far, only the role of skeletal muscle on plasma kynurenine has 
been studied. Further studies on other tissues such as fat and liver could increase our 
understanding of plasma kynurenine regulation. 
 
 DNA METHYLATION IN SKELETAL MUSCLES 6.3
DNA methylation was long thought to remain constant in differentiated cells. Recently, we 
and others have observed rapid DNA methylation profile changes in response to diverse 
stimuli including exercise, diet, lipids, and now insulin (Barres, Osler et al. 2009; Barres, Yan 
et al. 2012; Nitert, Dayeh et al. 2012; Ronn, Volkov et al. 2013; Lindholm, Marabita et al. 
2014; Dekkers, van Iterson et al. 2016). As noted in this thesis work, in skeletal muscle, 
methylome remodeling appears to be limited to a few of the DNA copies present in the 
samples. The exact origin of the changes remains unclear and warrants further investigations 
to determine which cells are affected, and what are the functional consequences of the DNA 
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methylation changes. Sorting of the cells and single cell sequencing could be helpful methods 
to achieve this goal. 
Furthermore, the interplay between DNA methylation marks and chromatin configuration, 
transcription factors binding, and mRNA transcription remains incompletely understood. 
Studying several of these aspects in a simpler model such as an immortalized cell line in vitro 
could help bridge the gap between the different levels of epigenetic regulation. For example 
in the case of Spry1 promoter, ChIP with DNA sequencing could help speed up the 
identification of regulatory transcription factors that bind in a methylation-dependent manner. 
Insulin and glucose have broad effects on growth and metabolism. Here we expand their 
potential roles to include direct effects on skeletal muscle DNA methylation, thereby 
providing an additional level of regulation. The epigenetic response to systemic factors 
associated with type 2 diabetes might be useful as biomarkers in the development of skeletal 
muscle insulin resistance or as targets for future treatments. The opposite effect of insulin 
stimulation in vitro compared to glucose stimulation in vivo on DAPK3 methylation may 
potentially be explained by changes in yet undescribed systemic factors. The identification of 
the factors overriding insulin signaling to control DAPK3 methylation would provide a new 
insight into DNA methylation regulation. 
Further work in these areas of research could provide a deeper insight into the mechanisms 
behind metabolic diseases and open new avenues to improve care management and create 
novel treatments. 
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